212 related articles for article (PubMed ID: 9253346)
1. Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor.
Ohta K; Pang XP; Berg L; Hershman JM
J Clin Endocrinol Metab; 1997 Aug; 82(8):2633-8. PubMed ID: 9253346
[TBL] [Abstract][Full Text] [Related]
2. The interaction of signal transduction pathways in FRTL5 thyroid follicular cells: studies with stable expression of beta 2-adrenergic receptors.
Tsuzaki S; Cone RD; Frazier AL; Moses AC
Endocrinology; 1991 Mar; 128(3):1359-68. PubMed ID: 1847855
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [3H]CGP 12177 binding to beta-adrenergic receptors in intact eel hepatocytes.
Fabbri E; Selva C; Moon TW; Capuzzo A
Gen Comp Endocrinol; 2001 Mar; 121(3):223-31. PubMed ID: 11254364
[TBL] [Abstract][Full Text] [Related]
4. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes.
Kimura K; Sasaki N; Asano A; Mizukami J; Kayahashi S; Kawada T; Fushiki T; Morimatsu M; Yoshida T; Saito M
Horm Metab Res; 2000 Mar; 32(3):91-6. PubMed ID: 10786926
[TBL] [Abstract][Full Text] [Related]
5. Beta 1-adrenergic regulation of the GT1 gonadotropin-releasing hormone (GnRH) neuronal cell lines: stimulation of GnRH release via receptors positively coupled to adenylate cyclase.
Martínez de la Escalera G; Choi AL; Weiner RI
Endocrinology; 1992 Sep; 131(3):1397-402. PubMed ID: 1354602
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 inhibits human thyroid carcinoma cell growth.
Kimura H; Yamashita S; Namba H; Tominaga T; Tsuruta M; Yokoyama N; Izumi M; Nagataki S
J Clin Endocrinol Metab; 1992 Aug; 75(2):596-602. PubMed ID: 1322431
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line.
Namba H; Yamashita S; Usa T; Kimura H; Yokoyama N; Izumi M; Nagataki S
Endocrinology; 1993 Feb; 132(2):839-45. PubMed ID: 8381075
[TBL] [Abstract][Full Text] [Related]
8. Regulation of beta 1- and beta 3-adrenergic agonist-stimulated lipolytic response in hyperthyroid and hypothyroid rat white adipocytes.
Germack R; Starzec A; Perret GY
Br J Pharmacol; 2000 Feb; 129(3):448-56. PubMed ID: 10711342
[TBL] [Abstract][Full Text] [Related]
9. Functional behavior of the beta-adrenergic receptor-adenylyl cyclase system in rabbit airway epithelium.
Mardini IA; Higgins NC; Zhou S; Benovic JL; Kelsen SG
Am J Respir Cell Mol Biol; 1994 Sep; 11(3):287-95. PubMed ID: 7916196
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.
Chen ST; Shieh HY; Lin JD; Chang KS; Lin KH
J Endocrinol; 2000 May; 165(2):379-89. PubMed ID: 10810302
[TBL] [Abstract][Full Text] [Related]
11. Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
Sawa A; Chiba T; Ishii J; Yamamoto H; Hara H; Kamma H
Endocr J; 2017 Nov; 64(11):1115-1123. PubMed ID: 28855436
[TBL] [Abstract][Full Text] [Related]
12. Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.
Pak MD; Fishman PH
J Recept Signal Transduct Res; 1996; 16(1-2):1-23. PubMed ID: 8771528
[TBL] [Abstract][Full Text] [Related]
13. Role of the adenylate cyclase-cAMP system on TSH-stimulated thyroid cell growth.
Marcocci C; Fenzi GF; Grollman EF
Acta Endocrinol Suppl (Copenh); 1987; 281():246-51. PubMed ID: 3039775
[TBL] [Abstract][Full Text] [Related]
14. Studies of catecholamine effect on cyclic AMP in human cultured thyroid cells: their interaction with thyrotrophin receptor.
Toccafondi RS; Brandi ML; Rotella CM; Zonefrati R
Acta Endocrinol (Copenh); 1983 Jan; 102(1):62-7. PubMed ID: 6130662
[TBL] [Abstract][Full Text] [Related]
15. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9.
Dahle MK; Myhre AE; Aasen AO; Wang JE
Infect Immun; 2005 Nov; 73(11):7290-6. PubMed ID: 16239525
[TBL] [Abstract][Full Text] [Related]
16. Effects of forskolin on adenylate cyclase, cyclic AMP, protein kinase and intermediary metabolism of the thyroid gland.
Totsuka Y; Ferdows MS; Nielsen TB; Field JB
Biochim Biophys Acta; 1983 Apr; 756(3):319-27. PubMed ID: 6299378
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
Stickle D; Barber R
Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture. Mediation via beta 1 but not via beta 3 adrenoceptors.
Bronnikov G; Houstĕk J; Nedergaard J
J Biol Chem; 1992 Jan; 267(3):2006-13. PubMed ID: 1346138
[TBL] [Abstract][Full Text] [Related]
20. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.
Derwahl M; Kuemmel M; Goretzki P; Schatz H; Broecker M
Biochem Biophys Res Commun; 1993 Mar; 191(3):1131-8. PubMed ID: 8385451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]